Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome

Gynecological Endocrinology

Volumn 10, Issue 4, 1996, Pages 249-255

  Gokmen O ^a   Senoz S ^a,b   Gulekli B ^a   Isik A Z ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Drug therapy; Hirsutism; Lipid profile; Polycystic ovary syndrome

Indexed keywords

CYPROTERONE ACETATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KETOCONAZOLE; LIPID; LOW DOSE ORAL CONTRACEPTIVE; SPIRONOLACTONE; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

EID: 0029828313     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609012316     Document Type: Article

References (18)

1. Adams, J., Polson, D. W. and Franks, S. (1986). Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355-9
2. Kirschner, M. A., Zucker, I. R. and Jespersen, D. (1976). Idiopathic hirsutism - an ovarian abnormality. N. Engl. J. Med., 294, 637-40
3. Şenöz, S., Özakşir, G., Turhan, N. Ö., Gülekli, B., Çaǧlar, T. and Gökmen, O. (1994). Lipid profiles in women with hirsutism and polycystic ovaries. Gynecol. Endocrinol., 8, 33-7
4. Ferriman, D. and Gallwey, J. D. (1961). Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440-8
5. Givens, J. R., Anderson, R. N., Wiser, W. L., Umstot, E. S. and Fish, S. A. (1976). The effectiveness of two oral contraceptives in supressing plasma androstenedione, testosterone, LH and FSH and in stimulating plasma testosterone binding capacity in hirsute women. Am. J. Obstet. Gynecol., 124, 333-9
6. Barth, J. H., Cherry, C. A., Wojnarowska, F. and Dawber, R. P. R. (1991). Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study. Clin. Endocrinol., 35, 5-10
7. Barth, J. H., Cherry, C. A., Wojnorowska, F. and Dawber, R. P. R. (1989). Spironolactone is an effective and well tolerated systemic anti-androgen therapy for hirsute women. J. Clin. Endocrinol. Metab., 68, 966-70
8. Vidal, P. A. J., Munoz, T. M. Jodar, G. E., Garcia, C. C. J., Lardelli, P., Ruiz, D. M. E. and Escobar, J. F. (1994). Ketaconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenism. Eur. J. Endocrinol., 130, 333-8
9. Serafini, P. and Lobo, R. A. (1985). The effects of spironolactone on adrenal steroidogenesis in hirsute women. Fertil. Steril., 44, 595
10. Young, R. L., Goldzieher, J. W. and Elkind-Hirsch, K. (1987). The endocrine effects of spironolactone used as an antiandrogen. Fertil. Steril., 48, 223-8
11. Weidmann, P. and Gerber, A. (1984). Effects of treatment with diuretics on serum lipoproteins. J. Cardiovasc. Pharmacol., 6 (Suppl.) S260-268
12. Venturoli, S., Fabbri, R., Dal Prato, L., Mantovani, B., Capelli, M., Magrini, O. and Flamigni, C. (1990). Ketaconazole therapy for women with acne and/or hirsutism. J. Clin. Endocrinol. Metab., 71, 335-9
13. Sobel, J. D. (1985). Management of recurrent vulvovaginal candidiasis with intermittant ketaconazole prophylaxis. Obstet. Gynccol., 65, 435-40
14. Lewis, J. H., Zimmerman, H. J., Benson, G. D. and Ishak, K. G. (1984). Hepatic injury associated with ketaconazole therapy. Gastroenterology, 86, 503-5
15. Martikainen, H., Heikkinen, J., Roukonen, A. and Kauppila, A. (1988). Hormonal and clinical effects of ketoconazole in hirsute women. J. Clin. Endocrinol. Metab., 66, 987-91
16. Henkin, Y., Como, J. A. and Oberman, A. (1992). Secondary dyslipidemia: inadvertent effects of drugs in clinical practice. J. Am. Med. Assoc., 267, 961-8
17. Gülekli, B., Turhan, N. Ö., Şenöz, S., Kükner, S., Oral, H. and Gökmen, O. (1993). Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: a comparative study. Gynecol. Endocrinol., 7, 273-7
18. Conway, G. S., Agrawal, R., Betteridge, D. J. and Jacobs, H. S. (1992). Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin. Endocrinol., 37, 119-25